
- Vol 38, Issue 6
Transgenerational Transmission of Resilience After Catastrophic Trauma
In this CME, learn how to design interventions to promote resilience, study their relative effectiveness, and implement them accordingly.
CATEGORY 1 CME
Premiere Date: June 20, 2021
Expiration Date: December 20, 2022
ACTIVITY GOAL
To recognize the role epigenetics in resilience after trauma, in both individuals who experience trauma and their descendants.
Learning Objectives
After participating in this activity, you should be better prepared to:
1. Understand how various mechanisms of epigenetics can potentially contribute to transgenerational transmission of resilience.
2. Discuss the various interpretations of the American Psychiatric Association’s definition of resilience.
3. Review the different treatment modalities that could prevent transmission of trauma.
4. Understand the potential variables that either strengthen or weaken an individual’s resilience and positive health outcomes.
TARGET AUDIENCE
This continuing education (CE) activity is intended for psychiatrists, psychologists, primary care physicians, physician assistants, nurse practitioners, and other health care professionals who seek to improve their care for patients with mental health disorders.
ACCREDITATION/CREDIT DESIGNATION/FINANCIAL SUPPORT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership Physicians’ Education Resource®, LLC and Psychiatric TimesTM. Physicians’ Education Resource®, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is funded entirely by Physicians’ Education Resource®, LLC. No commercial support was received.
OFF-LABEL DISCLOSURE/DISCLAIMER
This CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CE activity is for continuing medical education purposes only and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic or treatment options for a specific patient’s medical condition.
The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of Physicians’ Education Resource®, LLC.
FACULTY, STAFF, AND PLANNERS’ DISCLOSURES AND CONFLICT OF INTEREST (COI) MITIGATION
None of the staff of Physicians’ Education Resource®, LLC; Psychiatric TimesTM, the planners or the authors for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
For content-related questions, email
HOW TO CLAIM CREDIT
Once you have read the article, please use the following URL to evaluate and request credit:
Traumatic events are quite common; the
According to a
Why Epigenetics?
Epigenetics is the study of heritable changes that occur without directly altering the nucleotide sequence of a genome. Various epigenetic processes function to determine an individual’s phenotype and control the expression of various proteins and their corresponding functional pathways. Epigenetic mechanisms of transmission include CpG islands (sites in the genome containing large numbers of CpG dinucleotide repeats), histones, and noncoding RNA. Methylation, the process of adding or removing a methyl group (–CH3), can occur at CpG islands and on histone proteins. In addition, histones can be altered in a variety of other ways, including acetylation, ubiquitination, phosphorylation, and the addition or removal of various sugars. These modifications alter the capacity for further transcription factors to express a gene.
Exposure to traumatic events can produce long-term epigenetic changes in consistent regions of the genome.
Epigenetic Changes in Plants and Animals
The ability to transmit epigenetic changes caused by trauma has been seen within both
Animal models using rodents have also shown consistent patterns of transmission across multiple generations. Dias and Ressler showed that rodents conditioned with a fear response to acetophenone gave birth to F1 and F2 (second-generation) offspring exhibiting similar fear behaviors. They determined that a persistent CpG hypomethylation of the Olfr151 gene was largely responsible for the
Resilience and Posttraumatic Growth
Resilience is often cited as a key factor in preventing adverse changes in personality or affect in reaction to stressors experienced in one’s life.7,24-26 The American Psychiatric Association (APA)
Some researchers have highlighted a combination of core, internal, and external resilience factors that can also contribute to how one succeeds in life.32 Core resilience is largely defined by one’s genome. Internal resilience, on the other hand, is distinguished by learned and shared behaviors that can be influenced by family, friends, and life experiences. These involve the development of healthy behaviors such as autonomy, self-control, hardiness, toughness, coping style, past experiences, resourcefulness, social competence, and grit. External resilience focuses primarily on socioecological factors, such as support from one’s community and access to social and health care services. Recognizing the different ways in which resilience can manifest and understanding these manifestations in multifactorial terms is the best method of combating and resisting traumatic adversity.32 Standardizing measures of resilience and change with respect to trauma has, however, proven to be difficult across disparate events, populations, and generations.
One measure of the impact of trauma on an individual is posttraumatic growth (PTG), which was defined in 1996 by Tedeschi and Calhoun to describe
Dekel et al published
Human Epigenetics and Trauma
Our genome and epigenetics may provide explanations of human resilience in the face of trauma. For example, the FK506-binding protein 51 (FKBP5) is a biomolecule that appears to modulate our reaction to stress and ability to exhibit resilience. The FKBP5 gene
In another study of Holocaust survivors,
Genes that are responsible for regulation of the HPA axis may also confer resilience to trauma. For example, multiple studies have found that childhood trauma and mistreatment are a risk factor for methylation of the human glucocorticoid receptor (NR3C1) gene and changes to the HPA axis.41-43 The
Variations in single-nucleotide polymorphisms (SNPs), specifically rs10482672, were also found to increase the risk of psychopathology.
Reducing Risks, and Building Resilience
What can be done to prevent transmission of past trauma to future generations? Studies have shown that nonpharmacological treatment of trauma- and stressor-related disorders can induce epigenetic changes in the genome responsible for the HPA axis.23,36 Roberts et al examined the methylation of FKBP5 before and after exposure-based cognitive behavioral therapy (CBT) in patients previously diagnosed with agoraphobia. Those who reported benefits from CBT after completing treatment were found to have lower levels of methylation at a CpG island at intron 7 of FKBP5. The severity of symptoms was reduced by an average of 69.5% in those who received exposure-based CBT, which correlated with the decrease in methylation. Individuals who reported little change from CBT were found to have either no significant changes or even increases in methylation of CpG islands at intron 7 of FKBP5. The authors believed that FKBP5 may play a part in susceptibility to
Bishop et al found similar results in patients with PTSD who received mindfulness-based stress reduction interventions. These patients showed levels of methylation of intron 7 of FKBP5 significantly different after intervention compared with initial levels. Those who responded to treatment, as indicated by a 10-point drop in PTSD severity via a PTSD checklist, had
Family and community play a strong role in enhancing an individual’s resilience.
Likewise, the World Health Organization has found that the arts have contributed to the improvement of public health. Music, art, dance, and communication through storytelling about past events at an early age not only reduce anxiety but also protect against cognitive decline later in life. Exposure to and involvement with the arts “trigger psychological, physiological, social, and behavioral responses” associated with positive health outcomes that may be linked to
Exercise has long been associated with various health benefits and has been documented to be valuable for regulating reactions to stress, sleep, and resilience to mood disorders.55-58 In animal models, exercise serves a protective role in lowering the rates of
Patients diagnosed with trauma- and stressor-related disorders show evidence of dysregulation of their HPA axis, resulting in persistent personality changes.66-70 The diagnosis of Enduring Personality Change After Catastrophic Experience (EPCACE) is defined as an enduring personality change lasting at least 2 years that a patient experiences following a catastrophic stressor (ICD-10). Thus, the presence or absence of a diagnosis of EPCACE may serve as a predictive factor for resilience and vulnerability in the face of trauma.71 Long-lasting epigenetic changes may present themselves as enduring
Concluding Thoughts
As the COVID-19 pandemic waxes and wanes and the fear, grief, and stress of the pandemic itself and preventive social isolation measures take their toll, it is paramount that we identify the most trauma-vulnerable patients and populations early on. Individuals
Fortunately, those who are most vulnerable to isolation and demoralization are often most likely to benefit from preventive intervention,46 the need for which is all too evident in our current circumstances. At the same time, there is a lack of transgenerational studies of, and a dearth of instruments to reliably study, the effectiveness of interventions to promote resilience in communities.
With the COVID-19 pandemic coming to an end, it is time to apply what we know about potential biopsychosocial mechanisms for transgenerational resilience in order to design alternative interventions to promote such resilience. We can then study the relative effectiveness of such interventions and support those that are most effective, in keeping with considerations of social justice and equity. Otherwise, even as we win the battle to defeat COVID-19, we may lose the transgenerational war to
Mr Tang is a second-year medical student at Pacific Northwest University Health Sciences. Dr Tanaka is an assistant professor of psychiatry in the Oregon Health & Science University (OHSU) School of Medicine. Dr Bursztajn is the cofounder of the Program in Psychiatry and the Law at Harvard Medical School and President of the American Unit of the UNESCO Bioethics Chair (Haifa). He is the coauthor of Medical Choices, Medical Chances: How Patients, Families, and Physicians Can Cope with Uncertainty (1981/1990). He practices clinical and forensic psychiatry and risk management in Cambridge, Massachusetts.
The authors thank Raquelle Mesholam-Gately, PhD, and Anthony Cunningham, PhD, for their thoughtful reading of an earlier draft.
References
1. Knipscheer J, Sleijpen M, Frank L, et al.
2. Benjet C, Bromet E, Karam EG, et al.
3. Mehta D, Miller O, Bruenig D, David G, Shakespeare-Finch J.
4. Braga LL, Mello MF, Fiks JP.
5. Leon GR, Butcher JN, Kleinman M, et al.
6. Rieck M. The psychological state of Holocaust survivors’ offspring: an epidemiological and psychodiagnostic study. Int J Behav Dev. 1994;17(4):649-667.
7. Sagi-Schwartz A, Van IJzendoorn MH, Grossmann KE, et al.
8. Shrira A, Palgi Y, Ben-Ezra M, Shmotkin D.
9. Zannas AS, Wiechmann T, Gassen NC, Binder EB.
10. Blacker CJ, Frye MA, Morava E, et al.
11. Dudley KJ, Li X, Kobor MS, et al.
12. Goodman M, New A, Siever L.
13. Jawaid A, Roszkowski M, Mansuy IM.
14. Martos SN, Tang WY, Wang Z.
15. Xavier MJ, Roman SD, Aitken RJ, Nixon B.
16. Perez MF, Lehner B.
17. Suter L, Widmer A.
18. Migicovsky Z, Yao Y, Kovalchuk I.
19. Ganguly DR, Crisp PA, Eichten SR, Pogson BJ.
20. Jones AL, Sung S.
21. Dias BG, Ressler KJ.
22. Babb JA, Carini LM, Spears SL, Nephew BC.
23. Roberts S, Keers R, Lester KJ, et al.
24. Buckner JC, Mezzacappa E, Beardslee WR.
25. Masten AS, Best KM, Garmezy N. Resilience and development: contributions from the study of children who overcame adversity. Dev Psychopathol. 1990;2(4):425-444.
26. Schetter CD, Dolbier C.
27. Building your resilience. American Psychiatric Association. 2012. Accessed April 1, 2021.
28. Malhi GS, Das P, Bell E, Mattingly G, Mannie Z.
29. McEwen BS, Stellar E.
30. Sisto A, Vicinanza F, Campanozzi LL, et al.
31. Southwick SM, Bonanno GA, Masten AS, et al.
32. Liu JJ, Reed M, Girard TA. Advancing resilience: an integrative, multi-system model of resilience. Pers Individ Dif. 2017;111:111–118.
33. Tedeschi RG, Calhoun LG.
34. Tedeschi RG, Calhoun LG. Posttraumatic growth: conceptual foundations and empirical evidence. Psychol Inquiry. 2014;15(1):1-18.
35. Dekel S, Mandl C, Solomon Z.
36. Yehuda R, Daskalakis NP, Desarnaud F, et al.
37. Bevilacqua L, Carli V, Sarchiapone M, et al.
38. Grad I, Picard D.
39. Yehuda R, Daskalakis NP, Bierer LM, et al.
40. Miller O, Shakespeare-Finch J, Bruenig D, Mehta D.
41. Klengel T, Pape J, Binder EB, Mehta D.
42. McGowan PO, Sasaki A, D’Alessio AC, et al.
43. Perroud N, Paoloni-Giacobino A, Prada P, et al.
44. Oberlander TF, Weinberg J, Papsdorf M, et al.
45. Perroud N, Rutembesa E, Paoloni-Giacobino A, et al.
46. Albert D, Belsky DW, Crowley DM, et al.
47. VanZomeren-Dohm AA, Pitula CE, Koss KJ, et al.
48. Roberts S, Keers R, Breen G, et al.
49. Bishop JR, Lee AM, Mills LJ, et al.
50. Hwang WJ, Lee TY, Lim KO, et al.
51. Shastri PC.
52. Birkeland MS, Nielsen MB, Hansen MB, et al.
53. Freedman SA, Gilad M, Ankri Y, et al.
54. Fancourt D, Finn S. Health evidence network synthesis report 67: What is the evidence on the role of the arts in improving health and well-being? A scoping review. World Health Organization. 2019. Accessed April 2, 2021.
55. Callaghan P.
56. Fernandes J, Arida RM, Gomez-Pinilla F.
57. Fibbins H, Ward PB, Curtis J, et al.
58. Mandolesi L, Polverino A, Montuori S, et al.
59. Watanasriyakul WT, Wardwell J, McNeal N, et al.
60. Tillage RP, Wilson GE, Liles LC, et al.
61. Sharma A, Madaan V, Petty FD.
62. Pan-Vazquez A, Rye N, Ameri M, et al.
63. McGreevy KR, Tezanos P, Ferreiro-Villar I, et al.
64. Spindler C, Segabinazi E, Meireles ALF, et al.
65. Esteban-Cornejo I, Martinez-Gomez D, Tejero-González CM, et al.
66. Britvić D, Antičević V, Kaliterna M, et al.
67. Dashorst P, Mooren TM, Kleber RJ, et al.
68. Marinova Z, Maercker A.
69. Kozarić-Kovacić D, Kocijan-Hercigonja D.
70. Gescher DM, Kahl KG, Hillemacher T, Frieling H, Kuhn J, Frodl T.
71. Tanaka G, Tang H, Haque OS, Bursztajn HJ. How catastrophe can change personality: why EPCACE is a clinically useful diagnosis. Psychiatr Times. 2019;36(9):43,44,50.
72. Burtscher J, Burtscher M, Millet GP. (
73. Duncan LE, Ratanatharathorn A, Aiello AE, et al.
74. Nievergelt CM, Maihofer AX, Klengel T, et al.
75. Holt-Lunstad J, Smith TB, Baker M, et al.
76. Bursztajn H. Neither deaths from denial nor deaths from despair. Psychiatric Times. 2020;37(4). Accessed April 2, 2021.
Articles in this issue
over 5 years ago
The Opioid Addiction Crisis and Racism: A Long, Troubled Historyover 5 years ago
Avoid These Common Retirement Mistakesover 5 years ago
Modern Medieval Artistover 5 years ago
Exploring the Evolution of Depressionover 5 years ago
War—What Is It Good For? Perhaps Modern Psychopharmacologyover 5 years ago
Can Epigenetics Promote Resilience Without Genetic Reductionism?Related to this article

